vs
汉瑞祥（HSIC）与J.B. Hunt（JBHT）财务数据对比。点击上方公司名可切换其他公司
汉瑞祥的季度营收约是J.B. Hunt的1.1倍（$3.4B vs $3.1B），J.B. Hunt净利率更高（5.8% vs 2.9%，领先2.9%），汉瑞祥同比增速更快（7.7% vs -1.6%），汉瑞祥自由现金流更多（$338.0M vs $251.3M），过去两年汉瑞祥的营收复合增速更高（4.1% vs 2.6%）
汉瑞祥（Henry Schein, Inc.）是美国的医疗保健产品及服务分销商，业务覆盖全球33个国家和地区，是全球面向诊所类牙科及医疗从业者的最大医疗解决方案供应商。公司连续14年入选Ethisphere评选的「全球最具道德企业」榜单，2025年再次登榜。
J.B.亨特运输服务公司是总部位于美国阿肯色州洛厄尔的运输物流企业，1961年8月10日由约翰尼·布莱恩·亨特与乔内尔·亨特在阿肯色州创立。截至1983年，公司已成为美国第80大卡车运输企业，营收达6.2347亿美元，当时运营550台牵引车、1049辆挂车，拥有约1050名员工。
HSIC vs JBHT — 直观对比
营收规模更大
HSIC
是对方的1.1倍
$3.1B
营收增速更快
HSIC
高出9.3%
-1.6%
净利率更高
JBHT
高出2.9%
2.9%
自由现金流更多
HSIC
多$86.7M
$251.3M
两年增速更快
HSIC
近两年复合增速
2.6%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $3.4B | $3.1B |
| 净利润 | $101.0M | $181.1M |
| 毛利率 | 30.9% | — |
| 营业利润率 | 4.7% | 8.0% |
| 净利率 | 2.9% | 5.8% |
| 营收同比 | 7.7% | -1.6% |
| 净利润同比 | 7.4% | 16.5% |
| 每股收益（稀释后） | $0.85 | $1.88 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收HSICJBHT
| Q4 25 | $3.4B | $3.1B | ||
| Q3 25 | $3.3B | $3.1B | ||
| Q2 25 | $3.2B | $2.9B | ||
| Q1 25 | $3.2B | $2.9B | ||
| Q4 24 | $3.2B | $3.1B | ||
| Q3 24 | $3.2B | $3.1B | ||
| Q2 24 | $3.1B | $2.9B | ||
| Q1 24 | $3.2B | $2.9B |
净利润HSICJBHT
| Q4 25 | $101.0M | $181.1M | ||
| Q3 25 | $101.0M | $170.8M | ||
| Q2 25 | $86.0M | $128.6M | ||
| Q1 25 | $110.0M | $117.7M | ||
| Q4 24 | $94.0M | $155.5M | ||
| Q3 24 | $99.0M | $152.1M | ||
| Q2 24 | $104.0M | $135.9M | ||
| Q1 24 | $93.0M | $127.5M |
毛利率HSICJBHT
| Q4 25 | 30.9% | — | ||
| Q3 25 | 30.7% | — | ||
| Q2 25 | 31.4% | — | ||
| Q1 25 | 31.6% | — | ||
| Q4 24 | 31.1% | — | ||
| Q3 24 | 31.3% | — | ||
| Q2 24 | 32.5% | — | ||
| Q1 24 | 31.9% | — |
营业利润率HSICJBHT
| Q4 25 | 4.7% | 8.0% | ||
| Q3 25 | 4.9% | 7.9% | ||
| Q2 25 | 4.7% | 6.7% | ||
| Q1 25 | 5.5% | 6.1% | ||
| Q4 24 | 4.9% | 6.6% | ||
| Q3 24 | 4.9% | 7.3% | ||
| Q2 24 | 5.1% | 7.0% | ||
| Q1 24 | 4.7% | 6.6% |
净利率HSICJBHT
| Q4 25 | 2.9% | 5.8% | ||
| Q3 25 | 3.0% | 5.6% | ||
| Q2 25 | 2.7% | 4.4% | ||
| Q1 25 | 3.5% | 4.0% | ||
| Q4 24 | 2.9% | 4.9% | ||
| Q3 24 | 3.1% | 5.0% | ||
| Q2 24 | 3.3% | 4.6% | ||
| Q1 24 | 2.9% | 4.3% |
每股收益（稀释后）HSICJBHT
| Q4 25 | $0.85 | $1.88 | ||
| Q3 25 | $0.84 | $1.76 | ||
| Q2 25 | $0.70 | $1.31 | ||
| Q1 25 | $0.88 | $1.17 | ||
| Q4 24 | $0.75 | $1.53 | ||
| Q3 24 | $0.78 | $1.49 | ||
| Q2 24 | $0.80 | $1.32 | ||
| Q1 24 | $0.72 | $1.22 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $156.0M | $17.3M |
| 总债务越低越好 | $2.3B | — |
| 股东权益账面价值 | $3.2B | $3.6B |
| 总资产 | $11.2B | $7.9B |
| 负债/权益比越低杠杆越低 | 0.71× | — |
8季度趋势，按日历期对齐
现金及短期投资HSICJBHT
| Q4 25 | $156.0M | $17.3M | ||
| Q3 25 | $136.0M | $52.3M | ||
| Q2 25 | $145.0M | $50.9M | ||
| Q1 25 | $127.0M | $43.4M | ||
| Q4 24 | $122.0M | $47.0M | ||
| Q3 24 | $126.0M | $120.0M | ||
| Q2 24 | $138.0M | $53.5M | ||
| Q1 24 | $159.0M | $64.2M |
总债务HSICJBHT
| Q4 25 | $2.3B | — | ||
| Q3 25 | $2.2B | — | ||
| Q2 25 | $2.1B | — | ||
| Q1 25 | $2.0B | — | ||
| Q4 24 | $1.8B | $977.7M | ||
| Q3 24 | $1.9B | $1.0B | ||
| Q2 24 | $1.9B | $1.5B | ||
| Q1 24 | $2.0B | $1.4B |
股东权益HSICJBHT
| Q4 25 | $3.2B | $3.6B | ||
| Q3 25 | $3.4B | $3.6B | ||
| Q2 25 | $3.4B | $3.7B | ||
| Q1 25 | $3.3B | $3.9B | ||
| Q4 24 | $3.4B | $4.0B | ||
| Q3 24 | $3.5B | $4.0B | ||
| Q2 24 | $3.5B | $4.1B | ||
| Q1 24 | $3.6B | $4.2B |
总资产HSICJBHT
| Q4 25 | $11.2B | $7.9B | ||
| Q3 25 | $11.1B | $8.1B | ||
| Q2 25 | $10.9B | $8.2B | ||
| Q1 25 | $10.5B | $8.3B | ||
| Q4 24 | $10.2B | $8.3B | ||
| Q3 24 | $10.6B | $8.3B | ||
| Q2 24 | $10.3B | $8.4B | ||
| Q1 24 | $10.1B | $8.4B |
负债/权益比HSICJBHT
| Q4 25 | 0.71× | — | ||
| Q3 25 | 0.64× | — | ||
| Q2 25 | 0.61× | — | ||
| Q1 25 | 0.59× | — | ||
| Q4 24 | 0.54× | 0.24× | ||
| Q3 24 | 0.54× | 0.26× | ||
| Q2 24 | 0.54× | 0.36× | ||
| Q1 24 | 0.56× | 0.33× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $381.0M | $385.6M |
| 自由现金流经营现金流 - 资本支出 | $338.0M | $251.3M |
| 自由现金流率自由现金流/营收 | 9.8% | 8.1% |
| 资本支出强度资本支出/营收 | 1.3% | 4.3% |
| 现金转化率经营现金流/净利润 | 3.77× | 2.13× |
| 过去12个月自由现金流最近4个季度 | $573.0M | $947.6M |
8季度趋势，按日历期对齐
经营现金流HSICJBHT
| Q4 25 | $381.0M | $385.6M | ||
| Q3 25 | $174.0M | $486.4M | ||
| Q2 25 | $120.0M | $402.1M | ||
| Q1 25 | $37.0M | $404.2M | ||
| Q4 24 | $204.0M | $317.6M | ||
| Q3 24 | $151.0M | $338.5M | ||
| Q2 24 | $296.0M | $360.6M | ||
| Q1 24 | $197.0M | $466.5M |
自由现金流HSICJBHT
| Q4 25 | $338.0M | $251.3M | ||
| Q3 25 | $141.0M | $352.4M | ||
| Q2 25 | $88.0M | $185.6M | ||
| Q1 25 | $6.0M | $158.4M | ||
| Q4 24 | $168.0M | $93.3M | ||
| Q3 24 | $117.0M | $163.1M | ||
| Q2 24 | $259.0M | $98.2M | ||
| Q1 24 | $156.0M | $263.1M |
自由现金流率HSICJBHT
| Q4 25 | 9.8% | 8.1% | ||
| Q3 25 | 4.2% | 11.5% | ||
| Q2 25 | 2.7% | 6.3% | ||
| Q1 25 | 0.2% | 5.4% | ||
| Q4 24 | 5.3% | 3.0% | ||
| Q3 24 | 3.7% | 5.3% | ||
| Q2 24 | 8.3% | 3.4% | ||
| Q1 24 | 4.9% | 8.9% |
资本支出强度HSICJBHT
| Q4 25 | 1.3% | 4.3% | ||
| Q3 25 | 1.0% | 4.4% | ||
| Q2 25 | 1.0% | 7.4% | ||
| Q1 25 | 1.0% | 8.4% | ||
| Q4 24 | 1.1% | 7.1% | ||
| Q3 24 | 1.1% | 5.7% | ||
| Q2 24 | 1.2% | 9.0% | ||
| Q1 24 | 1.3% | 6.9% |
现金转化率HSICJBHT
| Q4 25 | 3.77× | 2.13× | ||
| Q3 25 | 1.72× | 2.85× | ||
| Q2 25 | 1.40× | 3.13× | ||
| Q1 25 | 0.34× | 3.43× | ||
| Q4 24 | 2.17× | 2.04× | ||
| Q3 24 | 1.53× | 2.23× | ||
| Q2 24 | 2.85× | 2.65× | ||
| Q1 24 | 2.12× | 3.66× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
HSIC
| Global Dental Merchandise | $1.2B | 35% |
| Global Medical | $1.1B | 31% |
| Global Dental Equipment | $536.0M | 16% |
| Global Specialty Products | $422.0M | 12% |
| Global Technology | $173.0M | 5% |
| Global Value Added Services | $64.0M | 2% |
| Equity Method Investee | $14.0M | 0% |
JBHT
| JBI | $1.5B | 50% |
| DCS | $842.8M | 27% |
| ICS | $304.5M | 10% |
| FMS | $206.3M | 7% |
| JBT | $200.7M | 6% |
